Exhibit 8
 Dr. Reddys Laboratories Limited
 Country of
    
    Percentage of Direct/Name of Subsidiary
    
    Incorporation
    
    Indirect Ownership InterestDRL Investments Limited
    
    India
    
    
    100
    %Reddy Pharmaceuticals Hong Kong Limited
    
    Hong Kong
    
    
    100
    %OOO JV Reddy Biomed Limited
    
    Russia
    
    
    100
    %Reddy Antilles N.V.
    
    Netherlands
    
    
    100
    %Reddy Netherlands B.V.
    
    Netherlands
    
    
    100
    %(1)Reddy US Therapeutics, Inc.
    
    U.S.A.
    
    
    100
    %(1)Dr. Reddys Laboratories, Inc.
    
    U.S.A.
    
    
    100
    %(10)Dr. Reddys Farmaceutica do Brasil Ltda
    
    Brazil
    
    
    100
    %Cheminor Investments Limited
    
    India
    
    
    100
    %Aurigene Discovery Technologies Limited
    
    India
    
    
    100
    %Aurigene Discovery Technologies, Inc.
    
    U.S.A.
    
    
    100
    %(3)Kunshan Rotam Reddy Pharmaceutical Co. Limited
    
    China
    
    
    51.33
    %(4)Dr. Reddys Laboratories (EU) Limited
    
    United Kingdom
    
    
    100
    %(10)Dr. Reddys Laboratories (U.K.) Limited
    
    United Kingdom
    
    
    100
    %(5)Dr. Reddys Laboratories (Proprietary) Limited
    
    South Africa
    
    
    100
    %(12)Reddy Cheminor S.A.
    
    France
    
    
    100
    %(2)OOO Dr. Reddys Laboratories Limited
    
    Russia
    
    
    100
    %Dr. Reddys Bio-sciences Limited
    
    India
    
    
    100
    %Promius Pharma LLC (formerly Reddy Pharmaceuticals, LLC)
    
    U.S.A.
    
    
    100
    %(6)Trigenesis Therapeutics, Inc.
    
    U.S.A.
    
    
    100
    %Industrias Quimicas Falcon de Mexico, SA de CV
    
    Mexico
    
    
    100
    %Reddy Holding GmbH
    
    Germany
    
    
    100
    %(7)Lacock Holdings Limited
    
    Cyprus
    
    
    100
    %betapharm Arzneimittel GmbH
    
    Germany
    
    
    100
    %(8)beta Healthcare Solutions GmbH
    
    Germany
    
    
    100
    %(8)beta institut fur sozialmedizinische Forschung und Entwicklung GmbH
    
    Germany
    
    
    100
    %(8)Reddy Pharma Iberia SA
    
    Spain
    
    
    100
    %Reddy Pharma Italia SPA
    
    Italy
    
    
    100
    %(7)Dr. Reddys Laboratories (Australia) Pty Ltd.
    
    Australia
    
    
    100
    %Dr. Reddys Laboratories SA
    
    Switzerland
    
    
    100
    %Eurobridge Consulting B.V.
    
    Netherlands
    
    
    100
    %(1)OOO DRS LLC
    
    Russia
    
    
    100
    %(9)Aurigene Discovery Technologies(Malaysia ) Sdn, Bhd
    
    Malaysia
    
    
    100
    %(3)Dr. Reddys New Zealand Limited (formerly Affordable Healthcare Limited)
    
    New Zealand
    
    
    100
    %(10)Dr. Reddys Laboratories Ilac Ticaret Limited
    
    Turkey
    
    
    100
    %Dr. Reddys SRL (formerly Jet Generici SRL)
    
    Italy
    
    
    100
    %(11)Chirotech Technology Limited
    
    United Kingdom
    
    
    100
    %(5)Dr. Reddys Laboratories Louisiana LLC
    
    U.S.A.
    
    
    100
    %(6)Dr. Reddys Pharma SEZ Limited
    
    India
    
    
    100
    %Dr. Reddys Laboratories International SA
    
    Switzerland
    
    
    100
    %(8)Idea2Enterprises (India) Pvt. Limited
    
    India
    
    
    100
    %Dr. Reddys Laboratories Romania SRL
    
    Romania
    
    
    100
    %(10)I-Ven Pharma Capital Limited
    
    India
    
    
    100
    %(13)Dr. Reddys Venezuela, C.A
    
    Venezula
    
    
    100
    %(13)Dr. Reddys Laboratories Tennessee, LLC
    
    U.S.A
    
    
    100
    %(6)
 
 (1)
    
    Indirectly owned through Reddy Antilles N.V.(2)
    
    Subsidiary under liquidation.




---



##### 



(3)
    
    Indirectly owned through Aurigene Discovery Technologies Limited.(4)
    
    Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary as we hold a 51.33% stake;
however, we account for this investment by the equity method and do not consolidate it in our
financial statements.(5)
    
    Indirectly owned through Dr. Reddys Laboratories (EU) Limited.(6)
    
    Indirectly owned through Dr. Reddys Laboratories, Inc.(7)
    
    Indirectly owned through Lacock Holdings Limited.(8)
    
    Indirectly owned through Reddy Holding GmbH.(9)
    
    Indirectly owned through Eurobridge Consulting B.V.(10)
    
    Indirectly owned through Dr. Reddys Laboratories SA.(11)
    
    Indirectly owned through Reddy Pharma Italia SPA(12)
    
    We acquired the 40% non-controlling interest in August 2010.(13)
    
    Indirectly owned through DRL Investments Limited